J2E erythrocytic differentiation (EPO): Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 14: | Line 14: | ||
|series=IN_VITRO DIFFERENTIATION SERIES | |series=IN_VITRO DIFFERENTIATION SERIES | ||
|species=Mouse (Mus musculus) | |species=Mouse (Mus musculus) | ||
|tet_config= | |tet_config=https://fantom.gsc.riken.jp/5/suppl/tet/EPO.tsv.gz | ||
|tet_file= | |tet_file=https://fantom.gsc.riken.jp/5/tet#!/search/?filename=mm9.cage_peak_phase1and2combined_tpm_ann_decoded.osc.txt.gz&file=1&c=1&c=134&c=131&c=132&c=135&c=136&c=137&c=138&c=141&c=142&c=143&c=144&c=145&c=146&c=147&c=148&c=149&c=150&c=151&c=152&c=153&c=157&c=154&c=155&c=158&c=159&c=160&c=161&c=162&c=163&c=164&c=165&c=166&c=167&c=168&c=169&c=170&c=171&c=172&c=173&c=176&c=175&c=177&c=178&c=179&c=180&c=181&c=182 | ||
|time_points= | |time_points= | ||
|time_span=48 hours | |time_span=48 hours | ||
|timepoint_design=Early focus | |timepoint_design=Early focus | ||
|tissue_cell_type=Erythrocytes | |tissue_cell_type=Erythrocytes | ||
|zenbu_config= | |zenbu_config=https://fantom.gsc.riken.jp/zenbu/gLyphs/#config=S2tJQUUwFZVqKAAH5_L8qC | ||
}} | }} |
Latest revision as of 17:29, 14 March 2022
Series: | IN_VITRO DIFFERENTIATION SERIES |
---|---|
Species: | Mouse (Mus musculus) |
Genomic View: | Zenbu |
Expression table: | FILE |
Link to TET: | TET |
Sample providers : | Peter Klinken |
Germ layer: | mesoderm |
Primary cells or cell line: | cell line |
Time span: | 48 hours |
Number of time points: | 16 |
Overview |
---|
Erythropoietin (Epo) is the hormone, which regulates red blood cell production1. It is produced primarily in the kidney, and binds to Epo receptors (Epor) on the surface of immature erythroid cells in the bone marrow, thereby initiating the final stages of red cell maturation[1,2]. Following binding of Epo to its cognate receptor, a series of intracellular signaling cascades are activated, including stimulation of the JAK/STAT and ras/MAP kinase pathways[3,4]. This leads to enhanced cell division, followed by terminal differentiation which is characterized by the production of hemoglobin. In addition, morphological changes occur involving a reduction in cell size, nuclear condensation, and eventually extrusion of the nucleus to produce reticulocytes. Mature red blood cells (erythrocytes) containing large amounts of hemoglobin then circulate around the body transporting oxygen and carbon dioxide [5]. |
Sample description |
---|
J2E model of Erythocytic differentiation |
Quality control |
---|
Expression of the following genes was assessed to determine the validity of this cell line as a model of Epo-induced erythroid differentiation (Figure 2). All these genes are required for normal erythroid differentiation. |
Profiled time course samples
Only samples that passed quality controls (Arner et al. 2015) are shown here. The entire set of samples are downloadable from FANTOM5 human / mouse samples
13063-139I3 | J2E erythroblastic leukemia response to erythropoietin | 00hr00min | biol_rep1 |
13064-139I4 | J2E erythroblastic leukemia response to erythropoietin | 00hr15min | biol_rep1 |
13065-139I5 | J2E erythroblastic leukemia response to erythropoietin | 00hr30min | biol_rep1 |
13066-139I6 | J2E erythroblastic leukemia response to erythropoietin | 00hr45min | biol_rep1 |
13067-139I7 | J2E erythroblastic leukemia response to erythropoietin | 01hr00min | biol_rep1 |
13068-139I8 | J2E erythroblastic leukemia response to erythropoietin | 01hr20min | biol_rep1 |
13069-139I9 | J2E erythroblastic leukemia response to erythropoietin | 01hr40min | biol_rep1 |
13070-140A1 | J2E erythroblastic leukemia response to erythropoietin | 02hr00min | biol_rep1 |
13071-140A2 | J2E erythroblastic leukemia response to erythropoietin | 02hr30min | biol_rep1 |
13072-140A3 | J2E erythroblastic leukemia response to erythropoietin | 03hr00min | biol_rep1 |
13073-140A4 | J2E erythroblastic leukemia response to erythropoietin | 03hr30min | biol_rep1 |
13074-140A5 | J2E erythroblastic leukemia response to erythropoietin | 04hr | biol_rep1 |
13075-140A6 | J2E erythroblastic leukemia response to erythropoietin | 06hr | biol_rep1 |
13076-140A7 | J2E erythroblastic leukemia response to erythropoietin | 12hr | biol_rep1 |
13077-140A8 | J2E erythroblastic leukemia response to erythropoietin | 24hr | biol_rep1 |
13078-140A9 | J2E erythroblastic leukemia response to erythropoietin | 48hr | biol_rep1 |
13129-140G6 | J2E erythroblastic leukemia response to erythropoietin | 00hr00min | biol_rep2 |
13130-140G7 | J2E erythroblastic leukemia response to erythropoietin | 00hr15min | biol_rep2 |
13132-140G9 | J2E erythroblastic leukemia response to erythropoietin | 00hr45min | biol_rep2 |
13133-140H1 | J2E erythroblastic leukemia response to erythropoietin | 01hr00min | biol_rep2 |
13134-140H2 | J2E erythroblastic leukemia response to erythropoietin | 01hr20min | biol_rep2 |
13135-140H3 | J2E erythroblastic leukemia response to erythropoietin | 01hr40min | biol_rep2 |
13136-140H4 | J2E erythroblastic leukemia response to erythropoietin | 02hr00min | biol_rep2 |
13137-140H5 | J2E erythroblastic leukemia response to erythropoietin | 02hr30min | biol_rep2 |
13138-140H6 | J2E erythroblastic leukemia response to erythropoietin | 03hr00min | biol_rep2 |
13139-140H7 | J2E erythroblastic leukemia response to erythropoietin | 03hr30min | biol_rep2 |
13140-140H8 | J2E erythroblastic leukemia response to erythropoietin | 04hr | biol_rep2 |
13141-140H9 | J2E erythroblastic leukemia response to erythropoietin | 06hr | biol_rep2 |
13142-140I1 | J2E erythroblastic leukemia response to erythropoietin | 12hr | biol_rep2 |
13143-140I2 | J2E erythroblastic leukemia response to erythropoietin | 24hr | biol_rep2 |
13144-140I3 | J2E erythroblastic leukemia response to erythropoietin | 48hr | biol_rep2 |
13195-141E9 | J2E erythroblastic leukemia response to erythropoietin | 00hr00min | biol rep3 |
13196-141F1 | J2E erythroblastic leukemia response to erythropoietin | 00hr15min | biol_rep3 |
13197-141F2 | J2E erythroblastic leukemia response to erythropoietin | 00hr30min | biol_rep3 |
13198-141F3 | J2E erythroblastic leukemia response to erythropoietin | 00hr45min | biol_rep3 |
13199-141F4 | J2E erythroblastic leukemia response to erythropoietin | 01hr00min | biol_rep3 |
13200-141F5 | J2E erythroblastic leukemia response to erythropoietin | 01hr20min | biol_rep3 |
13201-141F6 | J2E erythroblastic leukemia response to erythropoietin | 01hr40min | biol_rep3 |
13202-141F7 | J2E erythroblastic leukemia response to erythropoietin | 02hr00min | biol rep3 |
13203-141F8 | J2E erythroblastic leukemia response to erythropoietin | 02hr30min | biol_rep3 |
13204-141F9 | J2E erythroblastic leukemia response to erythropoietin | 03hr00min | biol_rep3 |
13205-141G1 | J2E erythroblastic leukemia response to erythropoietin | 03hr30min | biol_rep3 |
13206-141G2 | J2E erythroblastic leukemia response to erythropoietin | 04hr | biol_rep3 |
13207-141G3 | J2E erythroblastic leukemia response to erythropoietin | 06hr | biol_rep3 |
13208-141G4 | J2E erythroblastic leukemia response to erythropoietin | 12hr | biol_rep3 |
13209-141G5 | J2E erythroblastic leukemia response to erythropoietin | 24hr | biol_rep3 |
13210-141G6 | J2E erythroblastic leukemia response to erythropoietin | 48hr | biol_rep3 |